The euphoria of both year-end 2019 and year-end 2017 led to nasty market declines the following February.
President-elect Joe Biden delivers an address on the COVID-19 crisis on Tuesday afternoon.
President Trump signed a $900 billion coronavirus relief bill on Sunday night.
The Senate adjourned Tuesday without taking any action on a House bill to up the size of the new stimulus checks, as Senate Majority Leader Mitch McConnell's hint he would like to tie the issue to several others left the chamber in a holding pattern.
U.S. stocks ended the Tuesday session modestly lower, giving up early gains that saw major benchmarks score another round of all-time intraday highs.
A stock that was trading below $3 just last week is now commanding prices above $38.
Shares of Myovant Sciences soared 27% Monday, after its parent Sumitovant Biopharma unveiled an agreement with Pfizer Inc. to jointly develop a treatment for prostate cancer and women’s health in a deal worth up to $4.2 billion in upfront and p...
